Bandingkan Harga & Kinerja Bangun Karya Perkasa Jaya Tbk. (KRYA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bangun Karya Perkasa Jaya Tbk. dan Organon Pharma Indonesia Tbk.: Bangun Karya Perkasa Jaya Tbk. diperdagangkan di Rp67 (kapitalisasi pasar 111,48 M, volume 24 jam 20,86 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Bangun Karya Perkasa Jaya Tbk. dan Organon Pharma Indonesia Tbk. berukuran mirip dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| KRYA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 111,48 M | 104,4 M |
Volume | 20,86 jt | — |
Lot | 208,55 rb | — |
Perputaran | 1,39 M | — |
Harga Rata-rata | 66,8 | — |
Nilai Transaksi | 1,39 M | — |
Harga Ekuilibrium Indikatif | 67 | — |
Volume Ekuilibrium Indikatif | 1,5 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bangun Karya Perkasa Jaya Tbk.
PT Bangun Karya Perkasa Jaya Tbk (the "Entity") was established based on a Notarial Deed No. 2 dated January 7, 2007, of Ranti Nursukma H, S.H., Notary in Surabaya. The Entity started commercial operations in 2007.
Selengkapnya di halaman KRYA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
